A new inquiry has begun into the safety of widely prescribed antidepressant drugs including Seroxat and Prozac.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has set up an expert group of the Committee on Safety of Medicines to review selective serotonin re-uptake inhibitors (SSRIs). This comes in response to growing public concern about SSRIs.
The inquiry has been welcomed by Professor Alasdair Breckenridge, chair of MHRA, who said: "We are aware that there is ongoing interest amongst patients about withdrawal readtions, feelings of suicide and whether these are linked to SSRIs. As a result there will be an indepth investigation into these areas."
